According to the World Health Organization, lung cancer is the second leading malignancies and the first leading cause of death in the world in 2020. In recent years, although progress has been made in the treatment of lung cancer, the prognosis has not been significantly improved. Currently, age-standardized five-year net survival was in the range of 10–20% in most countries.
Screening is an effective method of secondary prevention. Identified lung cancer risk population can improve the benefit of lung cancer prevention and control. Some specific biomarkers, individual characteristics and lifestyles could be the risk predictors of lung cancer. Based on various regional condition, building lung cancer prediction models are necessary for lung cancer prevention and control. We need to identify the targeted biomarkers, clinical information, and lifestyle related risk factors of lung cancer. Through the series research of lung cancer diagnosis and treatment, these could provide new ideas and directions for lung cancer prevention and control.
This Research Topic aims at presenting the trend and recent advances on epidemiology, risk factors and early diagnosis/treatment of lung cancer in population-based database. We welcome submissions clarifying the epidemiology, prevalence and survival condition of lung cancer in local areas; as well as research aiming at identifying which population groups are suitable for lung cancer screening, and how to evaluate and improve the participation rate of lung cancer screening and its benefit. Furthermore, submissions identifying methods and applications of early-stage screening/diagnosis of lung cancer, and assessing clinical application and health economics value are also welcomed. Hopefully they can provide new ideas and directions for lung cancer prevention and control.
We welcome Original Research, Review, and Mini-review covering, but not limited to the following subjects:
1) Latest epidemiology of lung cancer, especially pathology type and survival of lung cancer in young age patients.
2) Evaluation of Low-Dose Computed Tomography Lung Cancer Screening Program in local areas.
3) High risk population assessment and risk assessment model studies of lung cancer screening.
4) Multi-omics research and application on diagnosis of early-stage lung cancer.
5) Biomarkers such as CTC and cfDNA research on screening of lung cancer.
6) Bioinformatics analysis of identifying the diagnosis and screening targets of lung cancer.
Please note: manuscripts consisting solely of bioinformatics or computational analysis of public genomic or transcriptomic databases which are not accompanied by validation (independent cohort or biological validation in vitro or in vivo) are out of scope for this section and will not be accepted as part of this Research Topic.
According to the World Health Organization, lung cancer is the second leading malignancies and the first leading cause of death in the world in 2020. In recent years, although progress has been made in the treatment of lung cancer, the prognosis has not been significantly improved. Currently, age-standardized five-year net survival was in the range of 10–20% in most countries.
Screening is an effective method of secondary prevention. Identified lung cancer risk population can improve the benefit of lung cancer prevention and control. Some specific biomarkers, individual characteristics and lifestyles could be the risk predictors of lung cancer. Based on various regional condition, building lung cancer prediction models are necessary for lung cancer prevention and control. We need to identify the targeted biomarkers, clinical information, and lifestyle related risk factors of lung cancer. Through the series research of lung cancer diagnosis and treatment, these could provide new ideas and directions for lung cancer prevention and control.
This Research Topic aims at presenting the trend and recent advances on epidemiology, risk factors and early diagnosis/treatment of lung cancer in population-based database. We welcome submissions clarifying the epidemiology, prevalence and survival condition of lung cancer in local areas; as well as research aiming at identifying which population groups are suitable for lung cancer screening, and how to evaluate and improve the participation rate of lung cancer screening and its benefit. Furthermore, submissions identifying methods and applications of early-stage screening/diagnosis of lung cancer, and assessing clinical application and health economics value are also welcomed. Hopefully they can provide new ideas and directions for lung cancer prevention and control.
We welcome Original Research, Review, and Mini-review covering, but not limited to the following subjects:
1) Latest epidemiology of lung cancer, especially pathology type and survival of lung cancer in young age patients.
2) Evaluation of Low-Dose Computed Tomography Lung Cancer Screening Program in local areas.
3) High risk population assessment and risk assessment model studies of lung cancer screening.
4) Multi-omics research and application on diagnosis of early-stage lung cancer.
5) Biomarkers such as CTC and cfDNA research on screening of lung cancer.
6) Bioinformatics analysis of identifying the diagnosis and screening targets of lung cancer.
Please note: manuscripts consisting solely of bioinformatics or computational analysis of public genomic or transcriptomic databases which are not accompanied by validation (independent cohort or biological validation in vitro or in vivo) are out of scope for this section and will not be accepted as part of this Research Topic.
